Making sense of the new cervical-cancer screening guidelines

New England Journal of Medicine

Volumn 365, Issue 23, 2011, Pages 2145-2147

  Feldman, Sarah ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLPOSCOPY; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MEDICAL SOCIETY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PELVIC EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; UTERINE CERVIX CANCER;

EID: 83155182849     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1112532     Document Type: Short Survey

References (4)

1. ACOG practice bulletin no. 109: cervical cytology screening. Obstet Gynecol 2009; 114:1409-20.
2. Preventive Services Task Force. Opportunities for public comment (http://www.uspreventiveservicestaskforce.org/ tfcomment.htm).
3. American Society for Colposcopy and Cervical Pathology. Cervical cancer screening and prevention: the role of molecular testing (http://www.asccp.org/ practice-management/ molecular-screening-symposium).
4. Vesco KK, Whitlock EP, Eder M, Burda BU, Senger CA, Lutz K. Risk factors and other epidemiologic considerations for cervical cancer screening: a narrative review for the U.S. Preventive Services Task Force. Ann Intern Med 2011 October 17 (Epub ahead of print).